Streetbeat News

Revenues

H

Hyatt Hotels Corporation (NYSE:H) announced plans to expand its luxury portfolio with over 35 new hotels and resorts set to open by 2025. These properties will be under various Hyatt brands, including Park Hyatt, Grand Hyatt, Miraval, Alila, Andaz, Thompson Hotels, and The Unbound Collection, as well as Inclusive Collection brands Zoëtry Wellness & Spa Resorts and Dreams Resorts & Spas, targeting highly sought-after global destinations.

Portfolio Pulse from Benzinga Newsdesk

December 06, 2023 | 8:05 am

PAC

Grupo Aeroportuario Del Pacifico reported a 0.7% increase in passenger traffic for November 2023 compared to the same month in 2022. However, the number of available seats decreased by 2.5% due to Pratt & Whitney engine revisions on the A320neo and A321neo fleet. Despite this, load factors improved from 80.2% to 82.8%. New routes were added, including Puerto Vallarta to Calgary by Flair, Los Cabos to Victoria by WestJet, and Montego Bay to Denver by United.

Portfolio Pulse from Benzinga Newsdesk

December 06, 2023 | 7:33 am

EVO

EVOTF

Evotec's insomnia drug, EVT201, has received approval from the Chinese medical authority through its partner Zhejiang Jingxin Pharmaceutical. Evotec is set to receive double-digit royalties on net sales and additional milestones based on commercial success and potential sub-licensing.

Portfolio Pulse from Benzinga Newsdesk

December 06, 2023 | 7:04 am

UMC

United Microelectronics (UMC) reported a 16.67% year-over-year decline in sales for November 2023, with revenues dropping from NT$22,545,442 thousand to NT$18,787,670 thousand. From January to November 2023, the company experienced a 20.25% decrease in sales compared to the same period in 2022.

Portfolio Pulse from Benzinga Newsdesk

December 06, 2023 | 6:45 am

NVS

Novartis has received FDA approval for Fabhalta, the first oral monotherapy for adults with Paroxysmal Nocturnal Hemoglobinuria (PNH). The approval is based on the APPLY-PNH trial, which showed patients switching to Fabhalta had significant increases in hemoglobin levels compared to those continuing on anti-C5 treatment. Fabhalta is now available for both previously treated and treatment-naïve patients and addresses a significant unmet need in PNH treatment.

Portfolio Pulse from Benzinga Newsdesk

December 06, 2023 | 6:21 am

TSLA

Tesla Inc (NASDAQ:TSLA) experienced a significant decline in vehicle registrations in the UK for November, with only 1,648 vehicles registered compared to 6,025 in the same month last year, a drop of nearly 73%. This decrease has also affected Tesla's market share, which is now at 1.05%. Despite the Model Y's absence from the top ten best-seller list for November, it remains the sixth best-selling car year-to-date in the UK. Overall BEV registrations fell by 17.1% year-on-year, but year-to-date BEV registrations are up 27.%. The SMMT suggests that recovery depends on fiscal incentives and investment in charging infrastructure.

Portfolio Pulse from Anan Ashraf

December 06, 2023 | 5:28 am

BTBT

Bit Digital reported a 24% increase in Bitcoin production in November 2023, producing 142.7 BTC. The company's active hash rate was around 2.25 EH/s as of November 30, 2023. Additionally, Bit Digital received an initial prepayment from its first customer for its Bit Digital AI business, with expected revenue of $35-37 million from the contract in 2024.

Portfolio Pulse from Benzinga Newsdesk

December 05, 2023 | 11:01 pm

DSGX

Descartes Systems Gr (NASDAQ:DSGX) reported Q3 earnings of $0.31 per share, consistent with the previous year, but missed sales estimates with $144.70M compared to the expected $146.25M. Despite the miss, sales increased by 19.13% from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

December 05, 2023 | 10:23 pm

AVAV

AeroVironment Inc (NASDAQ:AVAV) reported Q2 financial results surpassing estimates with $180.8 million in revenue and 97 cents EPS. Year-over-year revenue increased by 62%, and the company has a funded backlog of $487 million. The full-year 2024 revenue outlook is projected between $685 million to $705 million, with anticipated earnings of $2.46 to $2.70 per share. After hours, AVAV shares slightly increased by 0.02% to $141.25.

Portfolio Pulse from Adam Eckert

December 05, 2023 | 9:46 pm

POWL

Powell Industries reported a significant increase in Q4 2023 earnings per share (EPS) to $2.17 from $0.73 year-over-year. The company's revenue for the quarter was $209 million, surpassing the estimate of $196.794 million.

Portfolio Pulse from Benzinga Newsdesk

December 05, 2023 | 9:36 pm